Get startedLog in
    Picture of Kyverna Therapeutics logo

    KYTX — Kyverna Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Kyverna Therapeutics Announces Positive Primary Analysis Results From KYSA-8 Trial Of Miv-Cel In SPS

    Picture of Kyverna Therapeutics logoKyverna Therapeutics
    21/04/2026 23:51
    April 22 (Reuters) - Kyverna Therapeutics Inc KYTX.O:

KYVERNA THERAPEUTICS INC - ANNOUNCES POSITIVE PRIMARY ANALYSIS RESULTS FROM KYSA-8 TRIAL OF MIV-CEL IN SPS

KYVERNA THERAPEUTICS INC - TRIAL MEETS ALL SECONDARY ENDPOINTS WITH SIGNIFICANT IMPROVEMENTS IN SPS

Source text: ID:nGNXcf11X9

Further company coverage: KYTX.O

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Kyverna Therapeutics

    See all news